Synthetic Blood International, Inc. (SYBD) Changes Name to Oxygen Biotherapeutics, Inc.
7/1/2008 10:28:35 AM
More...
|
Synthetic Blood International, Inc. (SYBD) Shareholders Approve Name Change and Reincorporation
6/18/2008 10:19:49 AM
More...
|
Synthetic Blood International, Inc. (SYBD) Acquires Exclusive License to Use New Virginia Commonwealth University Intellectual Property
5/23/2008 8:26:16 AM
More...
|
Synthetic Blood International, Inc. (SYBD) Provides Updates On Phase II-B Clinical Trial Of Oxycyte; Additional Data Submitted End Of May
5/19/2008 8:41:51 AM
More...
|
Synthetic Blood International, Inc. (SYBD) to Open New Research Office at Virginia BioTechnology Research Park
5/7/2008 8:45:14 AM
More...
|
Synthetic Blood International, Inc. (SYBD) Comments on JAMA Article About Hemoglobin-Based Blood Substitutes
4/29/2008 8:52:29 AM
More...
|
Synthetic Blood International, Inc. (SYBD) to Seek Shareholder Approval for Name Change
4/22/2008 8:49:32 AM
More...
|
Synthetic Blood International, Inc. (SYBD) Announces Filing of Protocol for Phase II-b Oxycyte Clinical Trial
4/14/2008 9:03:49 AM
More...
|
Synthetic Blood International, Inc. (SYBD) Announces Plans to File Protocol for Phase II-b Oxycyte(R) Clinical Trial
4/4/2008 8:36:53 AM
More...
|
Synthetic Blood International, Inc. (SYBD) Announces New Leadership Roles to Continue Product Development Strategy
3/31/2008 9:20:33 AM
More...
|
|